George D. Yancopoulos

164.0k citations
430 papers · 103.1k indexed · 70 hit papers · h-index 161
Co-authors
Stanley J. WiegandNicholas W. GaleSamuel DavisNeil StahlDavid M. ValenzuelaPeter C. MaisonpierreDavid J. GlassJocelyn Holash
Topics
Angiogenesis and VEGF in Cancer (100 papers)Nerve injury and regeneration (39 papers)Lipid metabolism and disorders (39 papers)
Cited by
Developmental NeuroscienceImmunology and AllergyCellular and Molecular Neuroscience
Journals
NatureScienceNew England Journal of Medicine
Partner nations
United StatesGermanyUnited Kingdom

In The Last Decade

George D. Yancopoulos

428 papers receiving 100.9k citations

Hit Papers

Vascular-specific growth factors and blood vessel for...19842026199820122000199720011996200110002.0k3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vascular-specific growth factors and blood vessel formation
    2000 3.0k citations George D. Yancopoulos, Nicholas W. Gale et al. profile →
  2. Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
    1997 2.8k citations Stanley J. Wiegand, George D. Yancopoulos et al. Science profile →
  3. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy
    2001 2.8k citations Sue C. Bodine, Esther Latres et al. Science profile →
  4. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
    1996 2.3k citations George D. Yancopoulos et al. profile →
  5. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
    2001 2.1k citations Sue C. Bodine, Trevor N. Stitt et al. profile →
  6. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
    2012 1.8k citations George D. Yancopoulos, Neil Stahl et al. profile →
  7. Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
    1999 1.7k citations Jocelyn Holash, George D. Yancopoulos et al. Science profile →
  8. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
    1991 1.7k citations George D. Yancopoulos et al. profile →
  9. Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
    1996 1.6k citations George D. Yancopoulos et al. profile →
  10. The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription Factors
    2004 1.6k citations Trevor N. Stitt, Brian Clarke et al. profile →
  11. VEGF-Trap: A VEGF blocker with potent antitumor effects
    2002 1.3k citations Jocelyn Holash, Patricia Boland et al. Proceedings of the National Academy of Sciences profile →
  12. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
    1991 1.3k citations George D. Yancopoulos et al. profile →
  13. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
    2001 1.3k citations Sue C. Bodine, Brian Clarke et al. profile →
  14. Regulation of the Germinal Center Response by MicroRNA-155
    2007 1.2k citations Andrew Murphy, David M. Valenzuela et al. Science profile →
  15. Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
    1999 1.1k citations Gavin Thurston, George D. Yancopoulos et al. Science profile →
  16. NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression
    1990 1.1k citations Stanley J. Wiegand, George D. Yancopoulos et al. profile →
  17. Neurotrophin-3: a Neurotrophic Factor Related to NGF and BDNF
    1990 1.1k citations George D. Yancopoulos et al. Science profile →
  18. Angiopoietin-1 protects the adult vasculature against plasma leakage
    2000 1.1k citations Gavin Thurston, John S. Rudge et al. profile →
  19. Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation
    2007 1.0k citations Frederick W. Alt, George D. Yancopoulos et al. profile →
  20. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
    2014 1.0k citations Neil Stahl, George D. Yancopoulos et al. profile →
  21. Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
    2013 951 citations Allen Radin, Neil Stahl et al. profile →
  22. SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells
    2006 930 citations Andrew Murphy, David M. Valenzuela et al. profile →
  23. Regulation of Gliogenesis in the Central Nervous System by the JAK-STAT Signaling Pathway
    1997 852 citations Neil Stahl, George D. Yancopoulos et al. Science profile →
  24. Choice of STATs and Other Substrates Specified by Modular Tyrosine-Based Motifs in Cytokine Receptors
    1995 840 citations Neil Stahl, George D. Yancopoulos et al. Science profile →
  25. Association and Activation of Jak-Tyk Kinases by CNTF-LIF-OSM-IL-6 β Receptor Components
    1994 836 citations Neil Stahl, George D. Yancopoulos et al. Science profile →
  26. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
    2006 824 citations Christopher Daly, Nicholas Papadopoulos et al. profile →
  27. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
    2012 823 citations Nicholas Papadopoulos, Ashique Rafique et al. profile →
  28. Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1
    2002 785 citations Nicholas W. Gale, Gavin Thurston et al. profile →
  29. The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In Vivo
    1996 749 citations Thomas M. DeChiara, David M. Valenzuela et al. profile →
  30. Eph Receptors and Ligands Comprise Two Major Specificity Subclasses and Are Reciprocally Compartmentalized during Embryogenesis
    1996 731 citations Nicholas W. Gale, David M. Valenzuela et al. profile →
  31. CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors
    2008 731 citations Andrew Murphy, David M. Valenzuela et al. Journal of Clinical Investigation profile →
  32. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor
    1991 722 citations Trevor N. Stitt, David J. Glass et al. profile →
  33. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
    2020 719 citations Kristen E. Pascal, Min Ni et al. Science profile →
  34. Essential role for oncogenic Ras in tumour maintenance
    1999 697 citations Jocelyn Holash, George D. Yancopoulos et al. profile →
  35. Increased Vascularization in Mice Overexpressing Angiopoietin-1
    1998 680 citations Gavin Thurston, George D. Yancopoulos et al. Science profile →
  36. Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
    2008 674 citations George D. Yancopoulos, David M. Valenzuela et al. profile →
  37. Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt
    1999 670 citations Brian Clarke, Lorna Nuñez et al. Science profile →
  38. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, Angiopoietins, and ephrins in vascular development
    1999 641 citations Nicholas W. Gale, George D. Yancopoulos profile →
  39. A BDNF autocrine loop in adult sensory neurons prevents cell death
    1995 633 citations Thomas M. DeChiara, George D. Yancopoulos et al. profile →
  40. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
    2016 632 citations Neil Stahl, George D. Yancopoulos et al. profile →
  41. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
    1999 620 citations Jocelyn Holash, Stanley J. Wiegand et al. profile →
  42. Ligands for EPH-Related Receptor Tyrosine Kinases that Require Membrane Attachment or Clustering for Activity
    1994 610 citations Nicholas W. Gale, George D. Yancopoulos et al. Science profile →
  43. Ordered rearrangement of immunoglobulin heavy chain variable region segments.
    1984 610 citations Frederick W. Alt, George D. Yancopoulos et al. profile →
  44. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments
    1985 604 citations George D. Yancopoulos profile →
  45. An Insulin-Stimulated Protein Kinase Similar to Yeast Kinases Involved in Cell Cycle Control
    1990 600 citations George D. Yancopoulos et al. Science profile →
  46. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light.
    1992 600 citations George D. Yancopoulos et al. Proceedings of the National Academy of Sciences profile →
  47. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting
    2007 597 citations R.A. Renard, Nicholas W. Gale et al. Proceedings of the National Academy of Sciences profile →
  48. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130
    1992 593 citations Neil Stahl, George D. Yancopoulos et al. profile →
  49. Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts
    2004 589 citations Gavin Thurston, George D. Yancopoulos et al. profile →
  50. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
    2012 583 citations Andrew Murphy, David M. Valenzuela et al. profile →
  51. Tie2 Receptor Ligands, Angiopoietin-1 and Angiopoietin-2, Modulate VEGF-Induced Postnatal Neovascularization
    1998 559 citations George D. Yancopoulos et al. profile →
  52. Agrin Acts via a MuSK Receptor Complex
    1996 557 citations David J. Glass, Trevor N. Stitt et al. profile →
  53. LIFRβ and gp130 as Heterodimerizing Signal Transducers of the Tripartite CNTF Receptor
    1993 556 citations Neil Stahl, George D. Yancopoulos et al. Science profile →
  54. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
    2016 553 citations Leda Mannent, Allen Radin et al. profile →
  55. Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines
    1984 549 citations George D. Yancopoulos, Frederick W. Alt et al. profile →
  56. Targeting key proximal drivers of type 2 inflammation in disease
    2015 529 citations Neil Stahl, George D. Yancopoulos et al. profile →
  57. Interleukin-22 but Not Interleukin-17 Provides Protection to Hepatocytes during Acute Liver Inflammation
    2007 522 citations George D. Yancopoulos, David M. Valenzuela et al. profile →
  58. Development of the Primary Antibody Repertoire
    1987 518 citations Frederick W. Alt, George D. Yancopoulos et al. Science profile →
  59. The Receptor for Ciliary Neurotrophic Factor
    1991 516 citations David M. Valenzuela, George D. Yancopoulos et al. Science profile →
  60. Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
    2012 505 citations George D. Yancopoulos, Neil Stahl et al. profile →
  61. Differential expression of myc family genes during murine development
    1986 480 citations George D. Yancopoulos, Frederick W. Alt et al. profile →
  62. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
    2018 477 citations George D. Yancopoulos et al. Journal of Allergy and Clinical Immunology profile →
  63. Evinacumab for Homozygous Familial Hypercholesterolemia
    2020 470 citations David M. Weinreich, George D. Yancopoulos et al. profile →
  64. RNA Sequencing of Single Human Islet Cells Reveals Type 2 Diabetes Genes
    2016 439 citations Yurong Xin, Min Ni et al. profile →
  65. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
    2014 359 citations Allen Radin, George D. Yancopoulos et al. Journal of Allergy and Clinical Immunology profile →
  66. Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
    2019 330 citations Yu Bai, Tammy Huang et al. profile →
  67. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
    2021 258 citations David M. Weinreich, George D. Yancopoulos et al. profile →
  68. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
    2023 119 citations Elizabeth Laws, Leda Mannent et al. profile →
  69. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
    2024 102 citations Elizabeth Laws, Naimish Patel et al. profile →
  70. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
    2024 65 citations Marcus Maurer, Thomas B. Casale et al. Journal of Allergy and Clinical Immunology profile →

Peers

George D. Yancopoulos
Comparison fields: 5 of 173
  • Molecular Biology 55.1k
  • Cellular and Molecular Neuroscience 18.5k
  • Immunology 16.0k
  • Oncology 14.3k
  • Physiology 12.2k
Replace Peter Carmeliet with:
Peter Carmeliet Belgium
Christer Betsholtz Sweden
Pierre Chambon France
Roderick T. Bronson United States
Michael E. Greenberg United States
Neal G. Copeland United States
Napoleone Ferrara United States
Kari Alitalo Finland
Kozo Kaibuchi Japan
Hans Lassmann Austria
George D. Yancopoulos relative to Peter Carmeliet Belgium Peter Carmeliet's profile →
Citations per field
00.5×2×2.6×
Peter Carmeliet · 1×
Citations per year

Countries citing papers authored by George D. Yancopoulos

Since Specialization
Citations

This map shows the geographic impact of George D. Yancopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George D. Yancopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George D. Yancopoulos more than expected).

Fields of papers citing papers by George D. Yancopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George D. Yancopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George D. Yancopoulos. The network helps show where George D. Yancopoulos may publish in the future.

Co-authorship network of co-authors of George D. Yancopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of George D. Yancopoulos. A scholar is included among the top collaborators of George D. Yancopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George D. Yancopoulos. George D. Yancopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trialsbreakdown →
2024 ·Journal of Allergy and Clinical Immunology ·Marcus Maurer,Thomas B. Casale,Sarbjit S. Saini,Moshe Ben‐Shoshan,Ana M. Giménez‐Arnau,Jonathan A. Bernstein,Akiko Yagami,(unknown),Allen Radin,Heribert Staudinger,Naimish Patel,Nikhil Amin,Bolanle Akinlade,Chunpeng Fan,Déborah Bauer,George D. Yancopoulos,Kiran Patel,Leda Mannent,Elizabeth Laws
65
2
Structural Analysis of Cancer-relevant TCR-CD3 and Peptide-MHC Complexes by CryoEM
2023 ·Microscopy and Microanalysis ·Kei Saotome,Drew Dudgeon,(unknown),Michael J. Moore,Jennifer L. Jones,Yi Zhou,Ashique Rafique,George D. Yancopoulos,Andrew Murphy,John Lin,William C. Olson,Matthew C. Franklin
3
3
Activin E–ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice
2023 ·Proceedings of the National Academy of Sciences ·Rene C. Adam,(unknown),(unknown),Yuanqi Zhao,(unknown),Soo Min,Gábor Halász,Jason Mastaitis,Gurinder S. Atwal,Senem Aykul,Vincent Idone,Aris N. Economides,Luca A. Lotta,Andrew Murphy,George D. Yancopoulos,Mark W. Sleeman,Viktoria Gusarova
21
4
Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders
2021 ·Clinical Infectious Diseases ·David Stein,Ernesto Oviedo‐Orta,Wendy Kampman,Jennifer McGinniss,(unknown),(unknown),(unknown),Johnathan M. Lancaster,Ned Braunstein,George D. Yancopoulos,David M. Weinreich
7
5
Molecular taxonomy of human ocular outflow tissues defined by single-cell transcriptomics
2020 ·Proceedings of the National Academy of Sciences ·Gaurang Patel,Wen Fury,Hua Yang,María Gomez‐Caraballo,Yu Bai,Tao Yang,Christina Adler,(unknown),Min Ni,H Schmitt,Ying Hu,George D. Yancopoulos,W. Daniel Stamer,Carmelo Romano
79
6
Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
2019 ·Blood ·Dennis Cooper,Deepu Madduri,Suzanne Lentzsch,Sundar Jagannath,Jingjin Li,Anita Boyapati,Lieve Adriaens,(unknown),Min Zhu,Israel Lowy,David M. Weinreich,George D. Yancopoulos,Manish Sharma,Maria Karasarides,David Sternberg
31
7
Mice harboring the human SLC30A8 R138X loss-of-function mutation have increased insulin secretory capacity
2018 ·Proceedings of the National Academy of Sciences ·Sandra Kleiner,Daniel R. Gomez,(unknown),Erqian Na,(unknown),Katie Cavino,Yurong Xin,José Luis Vázquez Rojas,(unknown),Brian Zambrowicz,Gaëlle Carrat,Pauline Chabosseau,Ming Hu,Andrew Murphy,George D. Yancopoulos,Guy A. Rutter,Jesper Gromada
40
8
Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade
2016 ·Cancer Research ·Alexandra Eichten,(unknown),Alexander P. Adler,Li Zhang,Ella Ioffe,Asma Parveen,George D. Yancopoulos,John S. Rudge,Israel Lowy,Hsin Chieh Lin,Douglas MacDonald,Christopher Daly,Xunbao Duan,Gavin Thurston
47
9
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
2015 ·Proceedings of the National Academy of Sciences ·Kristen E. Pascal,Christopher M. Coleman,Alejandro O. Mujica,Vishal Kamat,Ashok Badithe,Jeanette Fairhurst,Charleen Hunt,(unknown),(unknown),Jeanne M. Sisk,Krystal Matthews,Robert Babb,Gang Chen,(unknown),Tammy Huang,William C. Olson,George D. Yancopoulos,Neil Stahl,Matthew B. Frieman,Christos A. Kyratsous
172
10
Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition
2012 ·Cancer Research ·Christopher Daly,Alexandra Eichten,Carla Castanaro,Elizabeth Pasnikowski,Alexander P. Adler,Alshad S. Lalani,Nicholas Papadopoulos,Alastair H. Kyle,Andrew I. Minchinton,George D. Yancopoulos,Gavin Thurston
180
11
Elements between the IgH variable (V) and diversity (D) clusters influence antisense transcription and lineage-specific V(D)J recombination
2010 ·Proceedings of the National Academy of Sciences ·Cosmas Giallourakis,Andrew Franklin,Chunguang Guo,Hwei-Ling Cheng,Hye Suk Yoon,Michael P. Gallagher,Thomas Perlot,Milena M. Andzelm,Andrew Murphy,Lynn E. Macdonald,George D. Yancopoulos,Frederick W. Alt
27
12
Ghrelin O -acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice
2010 ·Proceedings of the National Academy of Sciences ·Tong‐Jin Zhao,Guosheng Liang,(unknown),Xuefen Xie,Mark W. Sleeman,Andrew Murphy,David M. Valenzuela,George D. Yancopoulos,Joseph L. Goldstein,Michael S. Brown
358
13
Embryonic stem cell tumor model reveals role of vascular endothelial receptor tyrosine phosphatase in regulating Tie2 pathway in tumor angiogenesis
2009 ·Proceedings of the National Academy of Sciences ·Zhe Li,Hui Huang,Patricia Boland,Melissa G. Dominguez,Patricia Burfeind,Ka‐Man Venus Lai,(unknown),Nicholas W. Gale,Christopher Daly,Wojtek Auerbach,David M. Valenzuela,George D. Yancopoulos,Gavin Thurston
28
14
Sustained VEGF Blockade Results in Microenvironmental Sequestration of VEGF by Tumors and Persistent VEGF Receptor-2 Activation
2008 ·Molecular Cancer Research ·Angela V. Kadenhe‐Chiweshe,(unknown),Kimberly W. McCrudden,Jason S. Frischer,(unknown),Jianzhong Huang,Jason C. Fisher,Jay H. Lefkowitch,Nikki Feirt,John S. Rudge,Jocelyn Holash,George D. Yancopoulos,Jessica J. Kandel,Darrell J. Yamashiro
64
15
Inhibition of Corneal Angiogenesis by Topical Administration of VEGF Trap
2007 ·Investigative Ophthalmology & Visual Science ·(unknown),J. Cao,Hang Song,Daniel Dix,Donna Hylton,J.S. Rudge,George D. Yancopoulos,Stanley J. Wiegand
1
16
Inhibition of IL-1 Blocks Corneal Inflammation and Neovascularization
2003 ·Investigative Ophthalmology & Visual Science ·J. Cao,R.A. Renard,Hang Song,Ella Ioffe,(unknown),J.S. Rudge,Ellen Koehler-Stec,George D. Yancopoulos,Stanley J. Wiegand
1
17
Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells
2002 ·Journal of Clinical Investigation ·Akiyoshi Uemura,Minetaro Ogawa,Masanori Hirashima,Takashi Fujiwara,Shinji Koyama,Hitoshi Takagi,Yoshihito Honda,Stanley J. Wiegand,George D. Yancopoulos,Shin‐Ichi Nishikawa
18
18
Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF
2002 ·Journal of Clinical Investigation ·Vassiliki Poulaki,Wenying Qin,Antonia M. Joussen,(unknown),Stanley J. Wiegand,John S. Rudge,George D. Yancopoulos,Anthony P. Adamis
169
19
Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF
2002 ·Journal of Clinical Investigation ·Vassiliki Poulaki,Wenying Qin,Antonia M. Joussen,(unknown),Stanley J. Wiegand,John S. Rudge,George D. Yancopoulos,Anthony P. Adamis
10
20
Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophybreakdown →
2001 ·Science ·Sue C. Bodine,Esther Latres,Susanne Baumhueter,Venus Lai,Lorna Nuñez,Brian Clarke,William Poueymirou,(unknown),Erqian Na,Kumar Dharmarajan,Zhen‐Qiang Pan,David M. Valenzuela,Thomas M. DeChiara,Trevor N. Stitt,George D. Yancopoulos,David J. Glass
2828

About George D. Yancopoulos

George D. Yancopoulos is a scholar working on Developmental Neuroscience, Cellular and Molecular Neuroscience and Molecular Biology, having authored 430 papers that have together received 103.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (100 papers), Nerve injury and regeneration (39 papers) and Lipid metabolism and disorders (39 papers). The work is most often cited by research in Developmental Neuroscience (6.8k citations), Immunology and Allergy (6.4k citations) and Cellular and Molecular Neuroscience (18.5k citations). George D. Yancopoulos has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Stanley J. Wiegand, Nicholas W. Gale, Samuel Davis, Neil Stahl, David M. Valenzuela, Peter C. Maisonpierre, David J. Glass, Jocelyn Holash, Andrew Murphy and Frederick W. Alt. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter CarmelietBreakdown of academic impact, for papers by Christer BetsholtzBreakdown of academic impact, for papers by Pierre ChambonBreakdown of academic impact, for papers by Roderick T. BronsonBreakdown of academic impact, for papers by Michael E. GreenbergBreakdown of academic impact, for papers by Neal G. CopelandBreakdown of academic impact, for papers by Napoleone FerraraBreakdown of academic impact, for papers by Kari AlitaloBreakdown of academic impact, for papers by Kozo KaibuchiBreakdown of academic impact, for papers by Hans Lassmann
Rankless by CCL
2026